000 04534nam a22005895i 4500
001 978-3-319-32392-3
003 DE-He213
005 20180206183124.0
007 cr nn 008mamaa
008 160610s2016 gw | s |||| 0|eng d
020 _a9783319323923
_9978-3-319-32392-3
050 4 _aHD28-70
072 7 _aKJMV6
_2bicssc
072 7 _aPDG
_2bicssc
072 7 _aBUS087000
_2bisacsh
082 0 4 _a658.514
_223
245 1 0 _aManaging Risk in Nanotechnology
_h[recurso electrónico] :
_bTopics in Governance, Assurance and Transfer /
_cedited by Finbarr Murphy, Eamonn M. McAlea, Martin Mullins.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2016.
300 _aX, 240 p. 42 illus., 39 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aInnovation, Technology, and Knowledge Management,
_x2197-5698
505 0 _aCh 1 Nanomaterials and Nanotechnology Firms: A Typology -- Ch 2 A Bayesian Regression Methodology for Correlating Noisy Hazard and Structural Alert Parameters of Nano-materials -- Ch 3 Integrating the Social Impacts into Risk Governance of Nanotechnology -- Ch 4 International Cooperation on Nanosafety between Europe and Latin America -- Ch 5 The Inclusion of Data on Nanomaterials Transformations and Environmental Interactions into Existing Regulatory Frameworks -- Ch 6 INSCX exchange: the HUB approach to self-regulation in support of Risk Governance, Assurance and Transfer -- Ch 7 Applying "Safety by Molecular Design" Concepts to Nanomaterials Risk Management -- Ch 8 Is it too early to call for a moratorium on nanotechnology? -- Ch 9 "Nanotort" Liability at Common Law.
520 _aThis book aims to address how nanotechnology risks are being addressed by scientists, particularly in the areas of human health and the environment and how these risks can be measured in financial terms for insurers and regulators. It provides a comprehensive overview of nanotechnology risk measurement and risk transfer methods, including a chapter outlining how Bayesian methods can be used. It also examines nanotechnology from a legal perspective, both current and potential future outcomes. The global market for nanotechnology products was valued at
_22.9 billion in 2013 and increased to about
_26 billion in 2014. This market is expected to reach about
_64.2 billion by 2019, a compound annual growth rate (CAGR) of 19.8% from 2014 to 2019. Despite the increasing value of nanotechnologies and their widespread use, there is a significant gap between the enthusiasm of scientists and nanotechnology entrepreneurs working in the nanotechnology space and the insurance/regulatory sector. Scientists are scarcely aware that insurers/regulators have concerns about the potential for human and environmental risk and insurers/regulators are not in a position to access the potential risk. This book aims to bridge this gap by defining the current challenges in nanotechnology across disciplines and providing a number of risk management and assessment methodologies. Featuring contributions from authors in areas such as regulation, law, ethics, management, insurance and manufacturing, this volume provides an interdisciplinary perspective that is of value to students, academics, researchers, policy makers, practitioners and society in general.
650 0 _aBusiness.
650 0 _aManagement.
650 0 _aIndustrial management.
650 0 _aQuality control.
650 0 _aReliability.
650 0 _aIndustrial safety.
650 0 _aEconomic policy.
650 0 _aNanotechnology.
650 1 4 _aBusiness and Management.
650 2 4 _aInnovation/Technology Management.
650 2 4 _aR & D/Technology Policy.
650 2 4 _aNanotechnology.
650 2 4 _aQuality Control, Reliability, Safety and Risk.
700 1 _aMurphy, Finbarr.
_eeditor.
700 1 _aMcAlea, Eamonn M.
_eeditor.
700 1 _aMullins, Martin.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783319323909
830 0 _aInnovation, Technology, and Knowledge Management,
_x2197-5698
856 4 0 _zLibro electrónico
_uhttp://148.231.10.114:2048/login?url=http://dx.doi.org/10.1007/978-3-319-32392-3
912 _aZDB-2-ENG
942 _cLIBRO_ELEC
999 _c227607
_d227607